Stock POLAR POLARCOOL AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials PolarCool AB

Equities

POLAR

SE0012570422

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 18:00:00 2024-05-07 EDT 		5-day change 1st Jan Change
0.1125 SEK -3.85% Intraday chart for PolarCool AB -13.79% -57.22%
02-23 PolarCool AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
02-21 PolarCool to Offer Concussion Therapy to United Rugby Championship League's Cardiff Rugby MT

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022
Capitalization 1 24.1 9.926 13.94 51.86 13.34
Enterprise Value (EV) 1 17.16 9.83 5.07 47.5 13.31
P/E ratio -3.23 x -1.49 x -2.35 x -6.25 x -1.01 x
Yield - - - - -
Capitalization / Revenue - 37,603,757 x 20,596,861 x 69,481,474 x 7,006,147 x
EV / Revenue - 37,239,054 x 7,491,882 x 63,651,390 x 6,990,729 x
EV / EBITDA -8,053,395 x -1,513,607 x -792,945 x -7,254,733 x -1,208,609 x
EV / FCF -2,494,581 x -2,261,478 x -1,092,150 x -6,931,642 x -2,785,182 x
FCF Yield -0% -0% -0% -0% -0%
Price to Book 1.88 x 1.61 x 2.17 x 3.93 x 2.22 x
Nbr of stocks (in thousands) 2,690 2,690 3,592 10,050 12,293
Reference price 2 8.960 3.690 3.880 5.160 1.085
Announcement Date 19-02-18 20-06-09 21-04-14 22-04-13 23-04-05
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales - - 0.264 0.6767 0.7463 1.904
EBITDA - -2.131 -6.494 -6.394 -6.548 -11.01
EBIT 1 -0.0241 -2.202 -6.65 -6.823 -7.093 -12.19
Operating Margin - - -2,519.22% -1,008.35% -950.45% -640.53%
Earnings before Tax (EBT) 1 -0.0241 -2.202 -6.65 -6.867 -7.103 -12.19
Net income 1 -0.0241 -2.202 -6.65 -6.867 -7.103 -12.19
Net margin - - -2,519.47% -1,014.83% -951.72% -640.57%
EPS 2 -0.4823 -2.771 -2.472 -1.655 -0.8262 -1.070
Free Cash Flow - -6.881 -4.346 -4.642 -6.853 -4.778
FCF margin - - -1,646.67% -685.98% -918.27% -251%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 18-10-09 19-02-18 20-06-09 21-04-14 22-04-13 23-04-05
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 0 6.94 0.1 8.87 4.35 0.03
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - -6.88 -4.35 -4.64 -6.85 -4.78
ROE (net income / shareholders' equity) - -34.3% -70.1% -64% -49.9% -127%
ROA (Net income/ Total Assets) - -15.3% -37.6% -31.1% -24.5% -53%
Assets 1 - 14.37 17.71 22.1 28.95 23.01
Book Value Per Share 2 0.1200 4.760 2.290 1.790 1.310 0.4900
Cash Flow per Share 2 0.0200 2.580 0.0400 1.040 0.4300 0.1200
Capex - 0.01 0.79 1.33 2.87 0.5
Capex / Sales - - 298.2% 196.01% 385.06% 26.16%
Announcement Date 18-10-09 19-02-18 20-06-09 21-04-14 22-04-13 23-04-05
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Bio Medical Devices

1st Jan change Capi.
POLARCOOL AB Stock PolarCool AB
-57.22% 605K
MIMEDX GROUP, INC. Stock MiMedx Group, Inc.
-15.05% 1.1B
NIBEC CO., LTD. Stock NIBEC Co., Ltd.
-22.03% 126M
COLLPLANT BIOTECHNOLOGIES LTD. Stock CollPlant Biotechnologies Ltd.
+3.72% 75.91M
KIM FOREST ENTERPRISE CO., LTD. Stock Kim Forest Enterprise Co., Ltd.
+5.15% 60.02M
BONUS BIOGROUP LTD. Stock Bonus BioGroup Ltd.
-1.20% 51.7M
Bio Medical Devices
  1. Stock Market
  2. Equities
  3. POLAR Stock
  4. Financials PolarCool AB
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW